Literature DB >> 9863555

Whole hemisphere autoradiography of the postmortem human brain.

H Hall1, C Halldin, L Farde, G Sedvall.   

Abstract

Whole hemisphere autoradiography (WHA) with selective high-affinity radioligands is a new tool in studying the distribution of receptors and of other neuronal components postmortem in brains from controls vs. subjects with psychiatric and neurologic diseases. WHA can be performed with several different isotopes (e.g., 3H, 125I, and 11C), and is in addition to characterization studies also used as a tool in early radioligand development. Moreover, using this technique, high-resolution images are obtained that are complementary to those obtained in vivo with e.g., PET and SPECT. Results on dopamine and serotonin receptor subtypes as well as of their transporters show that WHA is a very suitable technique for the detailed characterization of the distribution in the whole human brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9863555     DOI: 10.1016/s0969-8051(98)00053-5

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  14 in total

1.  Continuous monitoring of post mortem temperature changes in the human brain.

Authors:  B Gulyás; J Dobai; G Szilágyi; G Csécsei; G Székely
Journal:  Neurochem Res       Date:  2006-03-29       Impact factor: 3.996

2.  The decrease of dopamine D₂/D₃ receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB₁ cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D₂/D₃ antagonist [³H]raclopride and the novel CB₁ inverse agonist [¹²⁵I]SD7015.

Authors:  Szabolcs Farkas; Katalin Nagy; Zhisheng Jia; Tibor Harkany; Miklós Palkovits; Sean R Donohou; Victor W Pike; Christer Halldin; Domokos Máthé; László Csiba; Balázs Gulyás
Journal:  Brain Res Bull       Date:  2012-03-07       Impact factor: 4.077

Review 3.  Considerations in the Development of Reversibly Binding PET Radioligands for Brain Imaging.

Authors:  Victor W Pike
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

Review 4.  In vitro imaging techniques in neurodegenerative diseases.

Authors:  Bengt Långström; Per E Andrén; Orjan Lindhe; Marie Svedberg; Håkan Hall
Journal:  Mol Imaging Biol       Date:  2007 Jul-Aug       Impact factor: 3.488

5.  Neuroimaging of mirtazapine enantiomers in humans.

Authors:  Donald F Smith; Søren B Hansen; Steen Jakobsen; Dirk Bender; Hélène Audrain; Mahmoud Ashkanian; Bo S Stork; Luciano Minuzzi; Håkan Hall; Raben Rosenberg
Journal:  Psychopharmacology (Berl)       Date:  2008-06-20       Impact factor: 4.530

6.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain.

Authors:  Katarina Varnäs; Christer Halldin; Håkan Hall
Journal:  Hum Brain Mapp       Date:  2004-07       Impact factor: 5.038

7.  Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography.

Authors:  Erkki Tupala; Håkan Hall; Kim Bergström; Tuija Mantere; Pirkko Räsänen; Terttu Särkioja; Jari Tiihonen
Journal:  Hum Brain Mapp       Date:  2003-10       Impact factor: 5.038

Review 8.  PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.

Authors:  Patrick Emond; Denis Guilloteau; Sylvie Chalon
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

9.  Synthesis and evaluation of 2-chloro N-[(S)-{(S)-1-[11 C]methylpiperidin-2-yl} (phenyl)methyl]3-trifluoromethyl-benzamide ([11 C]N-methyl-SSR504734) as a PET radioligand for glycine transporter 1.

Authors:  Takeshi Fuchigami; Akihiro Takano; Balázs Gulyás; Zhisheng Jia; Sjoerd J Finnema; Jan D Andersson; Ryuji Nakao; Yasuhiro Magata; Mamoru Haratake; Morio Nakayama; Christer Halldin
Journal:  EJNMMI Res       Date:  2012-07-09       Impact factor: 3.138

10.  Amphetamine decreases α2C-adrenoceptor binding of [11C]ORM-13070: a PET study in the primate brain.

Authors:  Sjoerd J Finnema; Zoë A Hughes; Merja Haaparanta-Solin; Vladimir Stepanov; Ryuji Nakao; Katarina Varnäs; Andrea Varrone; Eveliina Arponen; Päivi Marjamäki; Katariina Pohjanoksa; Lauri Vuorilehto; Phebian A Babalola; Olof Solin; Sarah Grimwood; Jukka Sallinen; Lars Farde; Mika Scheinin; Christer Halldin
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-13       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.